H35.132 Retinopathy of prematurity, stage 2, left eye

Name of the Condition

• Retinopathy of prematurity, stage 2, left eye

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 2 represents a mild to moderate phase where abnormal blood vessel growth is present but not yet severe. This stage may involve structural changes in the retina, such as a ridge or demarcation line, and requires monitoring to assess progression. Vision loss is uncommon at this stage, but timely intervention can prevent advancement to more severe forms.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth. Stage 2 reflects a transitional phase where vascular changes are evident but not yet advanced.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 2, ROP is typically asymptomatic and detected through routine screening. Structural changes in the retina, such as a ridge or demarcation line, may be visible during examination. Vision loss is rare at this stage, but progression to more severe stages can occur if left unmonitored.

Diagnosis

Diagnosis is made through dilated eye examinations using indirect ophthalmoscopy, typically performed by a pediatric ophthalmologist. The International Classification of Retinopathy of Prematurity (ICROP) is used to stage the condition. Stage 2 is confirmed by the presence of a ridge or demarcation line with abnormal blood vessel growth, without extraretinal fibrovascular proliferation. Screening guidelines recommend examinations based on gestational age and postnatal risk factors.

Treatment Options

Stage 2 ROP often requires close monitoring rather than active treatment, as spontaneous regression is common. If progression to more severe stages (e.g., stage 3 or higher) occurs, interventions such as laser photocoagulation or anti-VEGF therapy may be considered. Treatment decisions depend on the infant's overall health and the extent of retinal involvement.

Prognosis and Follow-Up

The prognosis for stage 2 ROP is generally favorable, with many cases resolving without intervention. However, regular follow-up is essential to monitor for progression. Infants with stage 2 may require ongoing screening until retinal vascularization is complete, typically by term corrected age. Long-term follow-up is recommended to assess visual development and detect late complications.

Complications

While vision loss is uncommon in stage 2, progression to more severe stages can lead to retinal detachment, scarring, or blindness. Rarely, untreated or advanced ROP may result in strabismus, amblyopia, or other visual impairments. Early detection and management reduce the risk of these complications.

Lifestyle & Prevention

Prevention focuses on minimizing risk factors, such as optimizing oxygen therapy and supporting fetal maturation. For infants at risk, routine screening and timely intervention are critical. Post-discharge care should include monitoring for visual development and adherence to follow-up appointments.

When to Seek Professional Help

Seek immediate evaluation if there are signs of worsening ROP, such as abnormal eye movements, a white pupil (leukocoria), or concerns about visual development. Regular screening is essential for premature infants, and any deviation from expected retinal findings should prompt further assessment.

Tips for Medical Coders

Code H35.132 is specific to retinopathy of prematurity, stage 2, affecting the left eye. Documentation should specify the eye involved and the stage of ROP. Ensure the diagnosis is supported by clinical findings, such as retinal examination results, and that the stage is clearly documented to justify the code. Avoid using this code for unilateral or bilateral cases without specifying the eye when applicable.